CAH

Cardinal Health
D

CAH

Arincen75/100B
271.74
USD
3.96
(1.48%)
Post Trading·270.81USD-0.93(-0.34%)
Last updated: · Delayed 15 min
Fair value327.68Plus-17%246Price 271.74410
Q1 FY2027 results
EPS3.26+10.9%Revenue67.51B+1.3%
OverviewFinancialsForecastEarningsDividendsCompany

Cardinal Health executives and insider trading

Jason Hollar sold 124,529 shares for 29.38M USD in 10 sales over the last twelve months, the last on 19 August 2026, and bought none on the open market.

Over the last twelve months Cardinal Health's insiders sold 261,345 shares for 61.62M USD in 35 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
35
Shares sold
261,345
Value sold
61.62M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
59.55M USD
0
6 months
59.55M USD
0
1 year
61.62M USD
0
2 years
80.85M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Jason Hollar CEOChief Executive Officer & Director53124,52929.38M USD—19 Aug 2026—
Stephen Mason CEOChief Executive Officer of GMPD segment5535,0008.27M USD—18 Aug 2026—
Deborah L. Weitzman CEOChief Executive Officer of Pharmaceutical & Specialty Solutions Segment617,3541.73M USD—18 Aug 2026—
Aaron E. Alt Chief Financial Officer5444,32810.45M USD—18 Aug 2026—
Jessica L. Mayer Chief Legal & Compliance Officer5729,4366.95M USD—18 Aug 2026—
Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services5614,3963.37M USD—18 Aug 2026—
Patricia Hemingway Hall Director—4,000918.88K USD—6 Feb 2026—
Mary C. Scherer Senior Vice President & Chief Accounting Officer—2,302546.47K USD—19 Aug 2026—

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
19 Aug 2026Mary C. SchererSale100237.4023.74K USD5,013Form 4
19 Aug 2026Mary C. SchererSale2,202237.39522.73K USD2,811Form 4
19 Aug 2026Jason HollarSale6,206233.221.45M USD228,926Form 4
19 Aug 2026Jason HollarSale3,457234.29809.94K USD225,469Form 4
19 Aug 2026Jason HollarSale5,704235.341.34M USD219,765Form 4
19 Aug 2026Jason HollarSale6,731236.461.59M USD213,034Form 4
19 Aug 2026Jason HollarSale16,187237.233.84M USD196,847Form 4
19 Aug 2026Jason HollarSale6,244237.881.49M USD190,603Form 4
18 Aug 2026Jason HollarSale21,407234.565.02M USD293,725Form 4
18 Aug 2026Jason HollarSale29,915235.517.05M USD263,810Form 4
18 Aug 2026Jason HollarSale16,208236.543.83M USD247,602Form 4
18 Aug 2026Jason HollarSale12,470237.252.96M USD235,132Form 4
18 Aug 2026Stephen MasonSale3,100234.59727.23K USD49,961Form 4
18 Aug 2026Stephen MasonSale8,195235.621.93M USD41,766Form 4
18 Aug 2026Stephen MasonSale10,876236.502.57M USD30,890Form 4

Common questions about Cardinal Health's executives and insiders

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.